Furthermore, Cox analyses showed that high TLR3 expression is a protective factor for breast cancer patients (Fig. 3G, hazard ratio [HR] = 0.85, 95% CI: 0.73–0.99, P = 0.049). This evidence concerns the gene TLR3 and breast carcinoma.